Find stats on top websites
Industry Landscape
The bioinformatics and AI in life sciences industry is rapidly expanding, driven by the explosion of multi-omics data. It's crucial for accelerating drug discovery, personalized medicine, and academic research, with a strong focus on automation, data integration, and reproducible science.
Total Assets Under Management (AUM)
Bioinformatics Market Size in United States
~USD 6.5 Billion
(15.0% CAGR)
- Increased R&D in genomics and proteomics.
- Growing demand for integrated data analysis solutions.
- Rise of cloud-based bioinformatics platforms.
Total Addressable Market
18.8 billion USD
Market Growth Stage
Pace of Market Growth
Emerging Technologies
Foundation Models for Biology
Large-scale AI models pre-trained on vast biological datasets (genomics, proteomics, clinical data) are emerging to understand complex biological systems and predict drug-target interactions.
Spatial Multi-omics
This technology allows for the simultaneous measurement of multiple omics layers (genomics, transcriptomics, proteomics) while preserving spatial context within tissues, revealing cellular interactions and disease mechanisms at unprecedented resolution.
Federated Learning in Healthcare
A decentralized machine learning approach that enables AI models to be trained across multiple data silos (e.g., hospitals, research institutions) without directly sharing sensitive patient or proprietary data, ensuring privacy and data security.
Impactful Policy Frameworks
NIH Data Management and Sharing Policy (2023)
Effective January 25, 2023, the NIH requires researchers to prospectively plan for and conduct data management and sharing for all research funded in whole or in part by NIH.
This policy directly benefits Via Scientific by increasing the demand for platforms that facilitate robust data management, sharing, and reproducibility, aligning with Foundry's core capabilities.
FDA My Health My Data Act (State-level, e.g., Washington 2023)
While not a federal law, several states (like Washington, effective July 23, 2023) have enacted or are considering comprehensive consumer health data privacy laws that go beyond HIPAA.
These state-level acts necessitate robust data governance and privacy features within bioinformatics platforms, which can be an advantage for Via Scientific's secure and compliant solutions.
NIST AI Risk Management Framework (AI RMF 1.0, 2023)
Published in January 2023, this framework from the National Institute of Standards and Technology provides voluntary guidance for managing risks associated with artificial intelligence systems.
This framework encourages the adoption of responsible AI practices, aligning with Via Scientific's focus on ethical AI and providing a competitive edge for platforms that can demonstrate adherence to such guidelines.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
